Quick Takeaways
- Streeterville Capital LLC filed SCHEDULE 13G/A for China SXT Pharmaceuticals, Inc. Common stock, $0.08 par value (SXTC).
- Disclosed ownership: 0%.
- Date of event: 17 Jan 2025.
Streeterville Capital LLC - 17 Jan 2025 SCHEDULE 13G/A Report for China SXT Pharmaceuticals, Inc. Common stock, $0.08 par value (SXTC)
- Filing Manager
- Streeterville Capital LLC
- Reporting Manager
- Streeterville Capital LLC
- Symbol
- SXTC
- Disclosed Ownership
- 0 shares
- Ownership
- 0%
- Form type
- SCHEDULE 13G/A
- Filing time
- 21 Jan 2025, 13:01:08 UTC
- Date of event
- 17 Jan 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"Streeterville Capital LLC disclosed 0% ownership in China SXT Pharmaceuticals, Inc. Common stock, $0.08 par value (SXTC) on 17 Jan 2025."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 21 Jan 2025, 13:01.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Official SEC Source
Backed by Schedule 13D/13G
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original FilingReporting Managers (3)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Streeterville Capital LLC | 0% | 0 | 0 | 0 | John Fife | President | |
| Streeterville Management LLC | 0% | 0 | 0 | 0 | John Fife | President | |
| John M Fife | 0% | 0 | 0 | 0 | John Fife | John Fife |